BioVie Inc. has announced a one-for-ten reverse stock split of its Class A common stock, effective July 7, 2025. This means every ten shares of the company's stock will be consolidated into one share, without changing the par value per share. The total number of authorized shares remains unchanged, and no fractional shares will be issued. Trading on The Nasdaq Capital Market will continue on a split-adjusted basis, with a new CUSIP number of 09074F504.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.